Watching 10x Genomics; Shares Move Higher As Illumina Announces It Is Launching Compact, Low-Cost Gene Sequencing Devices
Portfolio Pulse from Benzinga Newsdesk
10x Genomics shares are moving higher following Illumina's announcement of launching compact, low-cost gene sequencing devices. This development may positively impact 10x Genomics as it could benefit from increased accessibility and demand for gene sequencing technologies.
October 09, 2024 | 4:14 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
10x Genomics shares are rising due to Illumina's launch of new gene sequencing devices, which could increase demand for 10x Genomics' technologies.
The launch of Illumina's compact, low-cost gene sequencing devices is likely to increase the accessibility and demand for gene sequencing. As a company involved in genomics, 10x Genomics could benefit from this increased demand, leading to a positive impact on its stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80